Document Detail

Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study.
MedLine Citation:
PMID:  14512916     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: There is currently no definitive cure for urticaria pigmentosa (UP). Psoralen plus ultraviolet A therapy is efficacious in alleviating symptoms and reducing cutaneous lesions. OBJECTIVE: The purpose of this study was to assess the effect of ultraviolet A1 (UVA1) in adult patients with UP and to compare the effectiveness of high-dose (130 J/cm(2)/day for 10 days) and medium-dose (60 J/cm(2)/day for 15 days) UVA1 radiation. METHODS: Ten and 12 adult patients with UP were treated with high-dose or medium-dose UVA1, respectively. The number of skin lesions and dermal mast cells, the presence of Darier's sign, the intensity of pruritus, and quality of life measures were evaluated before, at the end of treatment, and 2 and 6 months later. RESULTS: Baseline characteristics were similar among the 2 groups of patients. In the majority of patients, the number of lesions was not significantly reduced. However, the number of mast cells in lesional skin decreased markedly in most patients by the end of treatment, and it remained low for the whole study period. Pruritus and quality of life improved considerably by the end of treatment, and the improvement was maintained during the 6-month follow up. No significant differences were observed between patients receiving high- or medium-dose UVA1. CONCLUSIONS: UVA1 phototherapy ameliorates both objective and subjective symptoms of adult patients with UP and induces long-term remission in most cases. Medium-dose UVA1 appears at least as effective as high-dose UVA1.
Tommaso Gobello; Cinzia Mazzanti; Donatella Sordi; Giorgio Annessi; Damiano Abeni; Luca M Chinni; Giampiero Girolomoni
Related Documents :
10524506 - Finger doses received during 153sm injections.
2016796 - The morphological and functional changes in rat bladder following photodynamic therapy ...
6830696 - Irritant reactions to dithranol in normal subjects and psoriatic patients.
23243936 - Double, suicidal intoxication with hydroxycarbamide--a case report.
11765026 - Evaluating the impact of hemp food consumption on workplace drug tests.
7850376 - Pcb metabolism, persistence, and health effects after occupational exposure: implicatio...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of the American Academy of Dermatology     Volume:  49     ISSN:  0190-9622     ISO Abbreviation:  J. Am. Acad. Dermatol.     Publication Date:  2003 Oct 
Date Detail:
Created Date:  2003-09-26     Completed Date:  2003-10-23     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7907132     Medline TA:  J Am Acad Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  679-84     Citation Subset:  IM    
Istituto de Dermopatico dell'Immacolata, IRCCS, Roma, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Middle Aged
Pilot Projects
Quality of Life
Ultraviolet Therapy / methods*
Urticaria Pigmentosa / therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Experience with New World cutaneous leishmaniasis in travelers.
Next Document:  Horizontal advancement flap for symmetric reconstruction of small to medium-sized cutaneous defects ...